18 and older, any sex, with Refractive Errors. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Distance Visual Acuity (VA)Primary· Day 30
VA was tested monocularly (each eye individually) without visual correction under photopic (well-lit) conditions. VA was measured in logMAR (logarithm of the minimum angle of resolution), with 0.1 logMAR increment corresponding to 5 letters, or 1 line, on an Early Treatment Diabetic Retinopathy Study (ETDRS) chart. A lower numeric value represents better visual acuity. Both eyes contributed to the analysis. No formal statistical hypothesis testing was planned.
Group
Value
95% CI
LID014341
-0.09
± 0.07
Biofinity
-0.09
± 0.07
Sponsor's own description
The purpose of this study is to assess the clinical performance of an investigational, coated silicone hydrogel contact lens over approximately 30 days of daily wear.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07460557 — Morphological Characteristics of the Maxillomandibular Region in a 3D Representation and the Refractive Status of the Ey
· recruiting
NCT06913491 — Efficacy of PEEK Acuity Versus ETDRS Chart for Assessment of Visual Acuity and Refractive Error
· active not recruiting
NCT07001124 — Comparative Efficacy of Duochrome Test Verse +1 Blur Test in Detecting Refracting Error Across Different Ages
· NA
· active not recruiting
NCT06668246 — Performance of Refractometers With Self-adjusting Lenses Compared to Cycloplegia in Children (REFRALENS)
· active not recruiting
NCT05458323 — Cognitive Level Enhancement Through Vision Exams and Refraction
· NA
· recruiting
Other Alcon Research trials
Trials by the same sponsor.
NCT06884202 — Evaluation of Delefilcon A Contact Lenses
· NA
· completed
NCT06784063 — Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)
· NA
· completed
NCT06571656 — Evaluation of the Safety and Tolerability of Ocular Lubricants
· NA
· terminated
NCT06660290 — A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes
· Phase 3
· completed
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alcon Research
Last refreshed: 30 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03586167.